1. Piperazine ferulate attenuates gentamicin-induced acute kidney injury via the NF-κB/NLRP3 pathway
   Dan Li et al, 2022, Phytomedicine CrossRef
2. Targeting ferroptosis: a new therapeutic opportunity for kidney diseases
   Zhiyong Long et al, 2024, Frontiers in Immunology CrossRef
3. Piperazine ferulate prevents high‑glucose‑induced filtration barrier injury of glomerular endothelial cells
   Yong-Yu Yang et al, 2021, Experimental and Therapeutic Medicine CrossRef
4. Hepatoprotective effect of diammonium glycyrrhizinate and neuroprotective effect of piperazine ferulate on AmB-induced liver and kidney injury by suppressing apoptosis in vitro and in vivo
   Xu He et al, 2024, Toxicon CrossRef
5. The Role of p66Shc in Diabetes: A Comprehensive Review from Bench to Bedside
   SeyedehFatemeh Mousavi et al, 2022, Journal of Diabetes Research CrossRef
6. Natural compounds efficacy in complicated diabetes: A new twist impacting ferroptosis
   Tingting Bao et al, 2023, Biomedicine & Pharmacotherapy CrossRef
7. Advances in Traditional Chinese Medicine research in diabetic kidney disease treatment
   Shiyi Shen et al, 2024, Pharmaceutical Biology CrossRef
8. Ferroptosis as a Novel Therapeutic Target for Diabetes and Its Complications
   Xi-Ding Yang et al, 2022, Frontiers in Endocrinology CrossRef
9. Ferroptosis: new insight into the mechanisms of diabetic nephropathy and retinopathy
   Luxin Li et al, 2023, Frontiers in Endocrinology CrossRef